【港股异动 | 基石药业-B(02616.HK)涨超7% 公司有望成为港股通标的 CS5007的IND申请获中国NMPA批准】智通财经APP获悉,基石药业-B(02616.HK)涨超7%,截至发稿,涨6.94%,报5.92港元,成交额2454.31万港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.